Singapore markets open in 8 hours 1 minute

Clever Leaves Holdings Inc. (CLVR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.3500-0.1400 (-3.12%)
As of 12:48PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close4.4900
Open4.4300
Bid0.0000 x 0
Ask0.0000 x 0
Day's range4.3500 - 4.4506
52-week range1.7160 - 10.5000
Volume6,020
Avg. volume19,722
Market cap7.633M
Beta (5Y monthly)1.53
PE ratio (TTM)N/A
EPS (TTM)-12.6300
Earnings date09 May 2024 - 13 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Clever Leaves Reports Fourth Quarter and Full Year 2023 Results

    - 2023 Revenue Increased 6% Year-Over-Year, with a 39% Increase in Full-Year Cannabinoid Revenue - - Drove Year-over-Year General and Administrative Expense Reductions of 26% in Q4 2023 and 24% for the Full Year - - Completed Sale of Non-Cannabinoid Herbal Brands Business on March 21, 2024 for $8.02 Million, Including $7.02 Million in Cash Paid at Closing - TOCANCIPÁ, Colombia, April 01, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”)

  • GlobeNewswire

    Clever Leaves and Paradise Seeds to Develop and Register Genetic Assets in Colombia

    TOCANCIPÁ, Colombia, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced today that through its partnership with award-winning Dutch seed bank, Paradise Seeds (“Paradise”), to develop and register high performance cannabis cultivars in Colombia, Clever Leaves will have exclusive license to cultivate some of these genetics, while Paradise will make other cultivars available to third

  • GlobeNewswire

    Clever Leaves Granted Australian GMP Certification for Cannabis Products by the Therapeutic Goods Administration (TGA)

    Multinational operator has been granted Australian GMP certification by the TGA for the manufacturing of cannabis products. Clever Leaves is the first and only medicinal cannabis company globally that has GMP certifications from the European Union, Colombia, Brazil and Australia. TOCANCIPÁ, Colombia, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a global medicinal cannabis company, announced today that it has been granted Australian GMP certification for it